Skip links
Companies
› United States › G1 Therapeutics, Inc.
Company registry profile
G1 Therapeutics, Inc. logo

G1 Therapeutics, Inc.

Private limited company (Ltd.) Inactive

in

From the registry

Registration details

Registration No.
1113254
Incorporation Date
2009-08-27
Address
Park, United States
Website
www.g1therapeutics.com/
Status
Inactive
Country
United States
Source: North Carolina Secretary of StateRegistry coverage
Registry summary

Company overview

G1 Therapeutics, Inc. is a company registered in United States under 1113254, and its current status with North Carolina Secretary of State is inactive. The company was incorporated on 27 August 2009 and lists its registered address as Park, United States. 5 shareholders are on record for G1 Therapeutics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn.

Data Provenance
This record is sourced directly from official government registries, including North Carolina Secretary of State.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Fisher Asset Management, LLC 15.7% North Carolina Secretary of State
JP Morgan Chase & Company 13.1% North Carolina Secretary of State
Vanguard Group Inc 12.1% North Carolina Secretary of State

Registry notes and limitations

Five shareholders are currently on record for G1 Therapeutics, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Fisher Asset Management, LLC, holding 15.7% — the largest recorded stake — followed by JP Morgan Chase & Company at 13.1%; the remaining 3 shareholders shown hold smaller stakes.

The register reports 20 shareholders in total, though only the top 5 by holding are shown in this view.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Officers

1

SS
Sandi  james Sandi  james ACTIVE

Residence
🇺🇸 United States
Occupation
Assistant Secretary

Registry notes and limitations

One officer is currently on record for G1 Therapeutics, Inc., filed with North Carolina Secretary of State. Sandi  james Sandi  james serves as Assistant Secretary.

Management authority at G1 Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Registry questions

Frequently asked questions

Who owns G1 Therapeutics, Inc.?

Five shareholders are currently on record for G1 Therapeutics, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Fisher Asset Management, LLC, holding 15.7% — the largest recorded stake — followed by JP Morgan Chase & Company at 13.1%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is G1 Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for G1 Therapeutics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does G1 Therapeutics, Inc. have on record?

5 shareholders are shown on record for G1 Therapeutics, Inc.. The register reports 20 in total; only the top 5 by holding are shown here.

What is G1 Therapeutics, Inc.'s company registration number?

G1 Therapeutics, Inc.'s registration number is 1113254, filed with North Carolina Secretary of State in United States. Its current status on the register is inactive.

Is G1 Therapeutics, Inc. still an active company?

G1 Therapeutics, Inc.'s status on North Carolina Secretary of State is listed as inactive, not currently active.

When was G1 Therapeutics, Inc. incorporated?

G1 Therapeutics, Inc. was incorporated on 27 August 2009, according to North Carolina Secretary of State.

What is G1 Therapeutics, Inc.'s registered address?

The registered address on file for G1 Therapeutics, Inc. is Park, United States.

What legal structure is G1 Therapeutics, Inc. registered as?

G1 Therapeutics, Inc. is registered as a Private limited company (Ltd.) in United States.

Who are the officers/directors of G1 Therapeutics, Inc.?

One officer is currently on record for G1 Therapeutics, Inc., filed with North Carolina Secretary of State. Sandi  james Sandi  james serves as Assistant Secretary. Management authority at G1 Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

This website uses cookies to improve your web experience.